130 related articles for article (PubMed ID: 30661295)
1. Assessment of individual bioequivalence using sufficient bootstrap procedure.
Beyaztas U
Pharm Stat; 2019 May; 18(3):388-398. PubMed ID: 30661295
[TBL] [Abstract][Full Text] [Related]
2. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence trials with the incomplete 3 x 3 crossover design.
Lim NK; Park SG; Stanek E
Biom J; 2005 Oct; 47(5):635-43. PubMed ID: 16385904
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
5. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
6. Two-stage designs for cross-over bioequivalence trials.
Kieser M; Rauch G
Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
[TBL] [Abstract][Full Text] [Related]
7. On population and individual bioequivalence.
Schall R; Luus HG
Stat Med; 1993 Jun; 12(12):1109-24. PubMed ID: 8210816
[TBL] [Abstract][Full Text] [Related]
8. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.
Gaudreault J; Potvin D; Lavigne J; Lalonde RL
Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bioequivalence using a multiplicative model.
Chow SC; Peace KE; Shao J
J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
[TBL] [Abstract][Full Text] [Related]
10. A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs.
Knahl SIE; Lang B; Fleischer F; Kieser M
Eur J Clin Pharmacol; 2018 May; 74(5):549-559. PubMed ID: 29362819
[TBL] [Abstract][Full Text] [Related]
11. Robust and bootstrap testing procedures for bioequivalence.
Shen CF; Iglewicz B
J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
[TBL] [Abstract][Full Text] [Related]
12. Controlling type 1 error rate for sequential, bioequivalence studies with crossover designs.
Rasmussen HE; Ma R; Wang JJ
Pharm Stat; 2019 Jan; 18(1):96-105. PubMed ID: 30370634
[TBL] [Abstract][Full Text] [Related]
13. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Chen YI; Huang CS
Stat Med; 2014 Feb; 33(5):786-97. PubMed ID: 24105871
[TBL] [Abstract][Full Text] [Related]
14. First measured plasma concentration value as C(max); impact on the C(max) confidence interval in bioequivalence studies.
Jackson A; Conner D; Miller R
Biopharm Drug Dispos; 2000 May; 21(4):139-46. PubMed ID: 11180192
[TBL] [Abstract][Full Text] [Related]
15. Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.
Tempelman RJ
J Anim Sci; 2004; 82 E-Suppl():E162-172. PubMed ID: 15471796
[TBL] [Abstract][Full Text] [Related]
16. Detection of outlying data in bioavailability/bioequivalence studies.
Liu JP; Weng CS
Stat Med; 1991 Sep; 10(9):1375-89. PubMed ID: 1925168
[TBL] [Abstract][Full Text] [Related]
17. A new approach for outliers in a bioavailability/bioequivalence study.
Liao JJ
J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
[TBL] [Abstract][Full Text] [Related]
18. Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations.
el-Tahtawy AA; Jackson AJ; Ludden TM
Pharm Res; 1994 Sep; 11(9):1330-6. PubMed ID: 7816765
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
